ResearchTechCrunch
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
#biotech#health#vision#neuroscience
English
Science Corporation has successfully implanted its vision-restoring chip, PRIMA, into its first patient suffering from Stargardt disease, a condition that leads to the gradual loss of central vision. The implant works by simulating the function of photoreceptors and is part of a broader effort to develop brain-computer interfaces for various medical applications.
中文
科学公司成功为其第一位患有斯塔加特病的患者植入了视力恢复芯片PRIMA，这种疾病导致中心视力逐渐丧失。该植入物通过模拟光感受器的功能，成为开发各种医疗应用的脑机接口更广泛努力的一部分。